Semaglutide In 2027 Medicare Price Negotiations; Most Other Drugs Lose Exclusivity By Then
15 Products Totaled $41bn In Annual Part D Spending
15 drugs that cost Medicare Part D $41bn in one year are slated for negotiated pricing in 2027 (Shutterstock) 
